Inside RIVANNA's BoneEnhance: Making Volumetric Ultrasound Easier to Read
Dr. Dereck Mush, MD, MBA
RIVANNA
Builds the Accuro XV volumetric ultrasound platform, with machine learning modules for musculoskeletal imaging.
What they do
RIVANNA develops the Accuro XV diagnostic ultrasound system for musculoskeletal imaging; its 510(k) clearance was announced in May 2026. BoneEnhance, a machine learning module that segments bone and surrounding tissue in volumetric ultrasound data to support 3D skeletal visualization, received FDA 510(k) clearance announced October 22, 2026. The company is based in Charlottesville, Virginia, and was co-founded by CEO Will Mauldin, PhD.
The record
- Vertical
- Medical Devices
- Sub-segment
- Musculoskeletal ultrasound
- Product type
- Device
- Stage
- Headquarters
- Charlottesville, United States
- Region
- North America
- Founded
- Not disclosed
- Total funding
- Undisclosed
Also in Medical Devices
Related on The Signal
Dr. Dereck Mush, MD, MBA
Point-of-Care Ultrasound Is the Quiet Revolution in Diagnostics
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
The 8 Most Innovative MedTech Devices Right Now
From a pacemaker the size of a vitamin to a scanner that books its own follow-up, these are the devices actually changing care in 2026.
Dr. Dereck Mush, MD, MBA
The Digital Health Valuation Reset: How Sword Health's Acquisition of Headspace Redefines Enterprise Whole-Person Care
Dr. Dereck Mush, MD, MBA